Regulator Says Pfizer Used Misleading Advertisement

Law360, New York (August 14, 2007, 12:00 AM EDT) -- Federal Regulators took drug company Pfizer Inc. to task on Monday for using misleading claims about the schizophrenia drug Geodon in an advertisement the drug company published in a professional journal.

The U.S. Food and Drug Administration posted a letter it had written to Pfizer on its Web site Monday, in which it claimed Pfizer's advertisement misbranded the drug in violation of the Federal Food, Drug and Cosmetic Act.

Geodon is used to treat acute agitation in schizophrenic patients. The FDA said the drug is associated...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.